Ulcerative Colitis

This is a strategic business move," he stressed.The loss of nearly 300 scientific jobs at P&G will be something of a blow to regional development efforts to promote Greater Cincinnati as a hub for life sciences research.But Millikin said its decision could be good news for local research institutions that have later-stage drugs in development that present viable licensing opportunities for P&G.Millikin said it was difficult to assess how big of an overall impact the decision would have on P&G's working relationships with local medical research institutions such as the University of Cincinnati and Cincinnati Children's Hospital.Officials in Mason and at CincyTechUSA, a regional development agency for high-tech and life sciences-based jobs, couldn't be reached late Friday.

They said earlier in the week that they hadn't heard anything of P&G's plans to reduce its research activities in the field.Millikin said Mason officials were informed of the decision on Friday.

P&G is the city's largest employer.In addition to serving as the global headquarters for P&G Pharmaceuticals, the company's Health Care Research Center in Mason is also the headquarters for its Personal Health Care (non-prescription medicatio...

He told the British magazine: ''Yeah, my personality is sure not easy to deal with sometimes.

''But I've stopped trying to change it and have realised that the way I am is what makes me so good in racing.'' Source GMMCAPSIS International Latest news about SPEED [18/02 - 02:25] Speed admits he’s arrogant The Californian’s own confession...

[09/01 - 09:39] Speed's tough road to F1 High expectations from the American [07/12 - 09:45] An American back on the grid Speed first US racer since 1993 [18/10 - 13:50] American Speed to drive for Red Bull The first American in F1 since Michael Andretti [26/07 - 02:07] Scott Speed closes championship gap In the GP2 Series 5 last news : F1 [18/02/06 - 02:38] Plans to axe British GP bends To make room for residential homes [18/02/06 - 02:34] Mosley defends Red Bull 'betrayal' Tyre changes for a better spectacle [18/02/06 - 02:29] Button could lose edge - Mansell Jenson has already made his millions...

[18/02/06 - 02:25] Speed admits he’s arrogant The Californian’s own confession...

[17/02/06 - 20:30] Mixed fortunes for Tiago Monteiro MF1’s final day of testing at Valencia News search Newsletter Archives 2006 January February Previous Archives 2005 Archives 2004 Archives 2003 Archives 2002 Archives 2001 Archives 2000 Archives 1999 Archives 1998 Archives SHOP Racing-Store Your shoppingonline...

The latest F1 highlights videos: previews, team...

(NWLS): New Life Scientific, Inc.

was formed with the intent to develop and commercialize novel biotech/pharmaceutical products including vaccines and stem cells based treatment modalities and to expand through our own research, collaborations, acquisitions and in-licensing.

NWLS utilizes its strategic geographical positioning in Europe to seek undiscovered, emerging and under-valued biotechnologies in the countries of Eastern Europe, with the further intent of their commercialization.

NWLS recently acquired Novo Life Scientific (Ukraine), the holder of a cooperation agreement with the Institute of Molecular Biology and Genetics of the Ukrainian Academy of Sciences (IMBG).

NWLS has also recently acquired PharmaTrials International (PTI), a provider of services in the areas of clinical trials, market research and the regulatory approval of products for pharmaceutical, biotech and medical device companies world wide.

Safe Harbor Statements under the Private Securities Litigation Reform Act of 1965: Those statements contained herein which are not historical are forward-looking statements, and as such, are subject to risks and uncertainties that could cause actual operating results to materially differ from those contained in the forward-looking statements.

Such statements include, but are not limited to, certain delays that are beyo...